FDA Orange Book · active-ingredient family
Spinosad
Spinosad is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:NATROBA · NDA 022408
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · suspension
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NATROBARLD | CIPHER | NDA 022408 | — | Jan 18, 2011 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9895388 | Nov 25, 2033 | in 7 yr 7 mo | U-3365 |
Spinosad — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
